A grand jury refused to indict George Henderson, a 61-year-old Alzheimer’s patient, after he was accused of drugs, punched unconscious and arrested by a police officer in Guthrie, Kentucky, last ...

Scientists have discovered that how well a person’s cells generate energy—what they call “bioenergetic age”—could be a strong ...

Researchers have discovered that a person's "bioenergetic age," reflecting how efficiently cells produce energy, strongly ...

With genetic testing, we know more than ever about this devastating disease—but genes are only one part of the story.

Scientists have discovered that a modified form of a natural compound found in rosemary and sage may hold potential for ...

Scientists at Scripps Research developed a stable form of carnosic acid, which enhanced memory function and improved ...

AL002 misses Phase 2 goal in early Alzheimer's. Key Phase 3 data for latozinemab in 2025. Click here to read why ALEC is a ...

Altimmune said on Thursday that it plans to test its lead experimental obesity drug, pemvidutide, to potentially treat ...

Noon, is tackling ALS and other neurological disorders with a bold, multi-targeted approach. Fueled by a personal encounter with an ALS advocate, Ben-Noon assembled a team of top scientists to develop ...

Obesity is a major global health issue, increasing the risk of heart disease, diabetes, and high blood pressure. Despite many ...

A person’s “bioenergetic age”—or how youthfully their cells generate energy—might be a key indicator of whether they’re at risk of developing Alzheimer’s disease, new research from Weill Cornell ...